Medicare is set to expand its coverage to include GLP-1 drugs for weight loss, marking a significant change in policy. This new coverage, which begins on July 1, will be the first time the federal health insurance program has paid for such medications.
Among the drugs expected to be covered are Wegovy and Zepbound. A new $50 GLP-1 Bridge Program is also scheduled to start on July 1, though many eligible seniors may not yet be aware of these upcoming benefits.
This landmark decision will provide access to obesity drug coverage for seniors enrolled in Medicare. This is a developing story and will be updated as details emerge.
